| 000 | 01859 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517211926.0 | ||
| 264 | 0 | _c20180717 | |
| 008 | 201807s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0194623 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKawakita, Norifumi | |
| 245 | 0 | 0 |
_aProtective effect of nicorandil on myocardial injury following percutaneous coronary intervention in older patients with stable coronary artery disease: Secondary analysis of a randomized, controlled trial (RINC). _h[electronic resource] |
| 260 |
_bPloS one _c2018 |
||
| 300 |
_ae0194623 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCoronary Artery Disease _xdrug therapy |
| 650 | 0 | 4 |
_aCoronary Vessels _xphysiology |
| 650 | 0 | 4 |
_aCreatine Kinase, MB Form _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Injuries _xetiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIschemic Preconditioning, Myocardial |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 |
_aNicorandil _xtherapeutic use |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 |
_aPercutaneous Coronary Intervention _xadverse effects |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 |
_aProtective Agents _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aEjiri, Kentaro | |
| 700 | 1 | _aMiyoshi, Toru | |
| 700 | 1 | _aKohno, Kunihisa | |
| 700 | 1 | _aNakahama, Makoto | |
| 700 | 1 | _aDoi, Masayuki | |
| 700 | 1 | _aMunemasa, Mitsuru | |
| 700 | 1 | _aMurakami, Masaaki | |
| 700 | 1 | _aNakamura, Kazufumi | |
| 700 | 1 | _aIto, Hiroshi | |
| 773 | 0 |
_tPloS one _gvol. 13 _gno. 4 _gp. e0194623 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0194623 _zAvailable from publisher's website |
| 999 |
_c28291521 _d28291521 |
||